+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Implantable Cardioverter Defibrillator"

From
Global Wearable Cardioverter Defibrillator Market Outlook 2028 - Product Thumbnail Image

Global Wearable Cardioverter Defibrillator Market Outlook 2028

  • Report
  • November 2020
  • 553 Pages
  • Global
From
From
UAE Cardiovascular Devices Market, By Region, By Competition Forecast & Opportunities, 2018-2028F - Product Thumbnail Image

UAE Cardiovascular Devices Market, By Region, By Competition Forecast & Opportunities, 2018-2028F

  • Report
  • November 2023
  • 83 Pages
  • United Arab Emirates United Arab Emirates
From
From
From
From
From
From
From
From
From
From
Global Cardiac Rhythm Management Devices, 2022 - Product Thumbnail Image

Global Cardiac Rhythm Management Devices, 2022

  • Report
  • January 2023
  • 87 Pages
  • Global
From
From
From
Loading Indicator

The Implantable Cardioverter Defibrillator (ICD) market is a segment of the Cardiovascular Devices market. ICDs are medical devices used to treat life-threatening arrhythmias, or abnormal heart rhythms. They are implanted in the chest and monitor the heart's electrical activity. When an abnormal rhythm is detected, the device delivers an electrical shock to restore normal rhythm. ICDs are used to treat ventricular tachycardia and ventricular fibrillation, two of the most common causes of sudden cardiac death. The ICD market is driven by the increasing prevalence of cardiovascular diseases, technological advancements, and the growing demand for minimally invasive treatments. The market is expected to grow at a steady rate over the forecast period. Some of the major players in the ICD market include Medtronic, Abbott, Boston Scientific, Biotronik, LivaNova, and Sorin Group. Show Less Read more